glp-1 gip therapy alternatives after discontinuation Nutritional priorities to support for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society - 🔬 GLP-1/GIP Therapy Discontinuation: Why

not using GLP-1 receptor agonists had significantly lower relative risks for mortality and respiratory failure, according to a presentation at the CHEST Annual Meeting.In a retrospective study, Saud Alawad, MBBS, third-year internal medicine resident at West Virginia University, and colleagues analyzed adults with a group 1 PAH

GLP-1 medications can provide major health benefits, but recent studies have raised questions about a possible link with NAION, a rare optic nerve condition that can cause sudden vision loss

However, no direct link has been found between GLP-1R agonists and higher pulmonary aspiration risk

95% CI 0.97, 1.15)

OSA coverage requires BMI 27

Foundayo and oral Wegovy have arrived